RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mega Lifesciences PCL - Stock

Mega Lifesciences PCL P/S 2024

Mega Lifesciences PCL P/S

2.12

Ticker

MEGA.BK

ISIN

TH4984010009

As of Jun 15, 2024, Mega Lifesciences PCL's P/S ratio stood at 2.12, a -5.36% change from the 2.24 P/S ratio recorded in the previous year.

The Mega Lifesciences PCL P/S history

Mega Lifesciences PCL Aktienanalyse

What does Mega Lifesciences PCL do?

Mega Lifesciences PCL is a global healthcare company focused on innovative solutions and products for improving the health and well-being of people. It was founded in 1984 and is based in Bangkok, Thailand. The company operates in over 30 countries worldwide and employs over 5,000 employees. It started as a distribution-focused company but soon began developing its own products, starting with a dietary supplement called Bio-C Plus. Mega Lifesciences has grown through acquisitions and expanded its product portfolio. Its business model focuses on nutrition, health, and wellness, with a strong presence in Asia, Africa, Europe, and Latin America. The company is divided into different divisions including healthcare products, dietary supplements, veterinary medicine, and licensed products. Some of its products include Megaheart for cardiovascular diseases, Megamycin as an antibiotic, Megavit as a dietary supplement, Megaderm for skin diseases in animals, and licensed products from international pharmaceutical and healthcare companies. Mega Lifesciences aims to improve people's lives and promote their health through its diverse range of products. Mega Lifesciences PCL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Mega Lifesciences PCL's P/S Ratio

Mega Lifesciences PCL's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Mega Lifesciences PCL's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Mega Lifesciences PCL's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Mega Lifesciences PCL’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Mega Lifesciences PCL Stock

What is the price-to-earnings ratio of Mega Lifesciences PCL?

The price-earnings ratio of Mega Lifesciences PCL is currently 2.12.

How has the price-earnings ratio of Mega Lifesciences PCL changed compared to last year?

The price-to-earnings ratio of Mega Lifesciences PCL has increased by -5.36% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Mega Lifesciences PCL high compared to other companies?

Yes, the price-to-earnings ratio of Mega Lifesciences PCL is high compared to other companies.

How does an increase in the price-earnings ratio of Mega Lifesciences PCL affect the company?

An increase in the price-earnings ratio of Mega Lifesciences PCL would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Mega Lifesciences PCL affect the company?

A decrease in the price-earnings ratio of Mega Lifesciences PCL would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Mega Lifesciences PCL?

Some factors that influence the price-earnings ratio of Mega Lifesciences PCL are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Mega Lifesciences PCL pay?

Over the past 12 months, Mega Lifesciences PCL paid a dividend of 1.65 THB . This corresponds to a dividend yield of about 4.4 %. For the coming 12 months, Mega Lifesciences PCL is expected to pay a dividend of 1.91 THB.

What is the dividend yield of Mega Lifesciences PCL?

The current dividend yield of Mega Lifesciences PCL is 4.4 %.

When does Mega Lifesciences PCL pay dividends?

Mega Lifesciences PCL pays a quarterly dividend. This is distributed in the months of September, April, September, April.

How secure is the dividend of Mega Lifesciences PCL?

Mega Lifesciences PCL paid dividends every year for the past 13 years.

What is the dividend of Mega Lifesciences PCL?

For the upcoming 12 months, dividends amounting to 1.91 THB are expected. This corresponds to a dividend yield of 5.09 %.

In which sector is Mega Lifesciences PCL located?

Mega Lifesciences PCL is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mega Lifesciences PCL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mega Lifesciences PCL from 4/22/2024 amounting to 0.8 THB, you needed to have the stock in your portfolio before the ex-date on 3/6/2024.

When did Mega Lifesciences PCL pay the last dividend?

The last dividend was paid out on 4/22/2024.

What was the dividend of Mega Lifesciences PCL in the year 2023?

In the year 2023, Mega Lifesciences PCL distributed 1.16 THB as dividends.

In which currency does Mega Lifesciences PCL pay out the dividend?

The dividends of Mega Lifesciences PCL are distributed in THB.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mega Lifesciences PCL

Our stock analysis for Mega Lifesciences PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mega Lifesciences PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.